| Financier | Commitments |
|---|---|
| Global Financing Facility | 15.00 |
| IDA Credit | 15.00 |
| IDA Grant | 15.00 |
Additional Financing to the COVID-19 Emergency Response Project
Abstract*
This Additional Financing is being proposed at a crucial juncture in the Government’s response to COVID-19 with the recent surge in cases and the imminent availability of vaccines. The AF will play a critical role in enabling affordable and equitable access to vaccines for Rwanda. There is broad based recognition that economies will not recover fully until people feel they can live, socialize, work, and travel with confidence. Given the importance... Show More
Development Objective
To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in the Republic of Rwanda, and provide immediate and effective response in the case of an eligible crisis or emergency
Key Details
Project Details
P176304
Active
Amparo Gordillo-Tobar
Ministry of Finance (MINECOFIN)
Rwanda
March 14, 2021
(as of board presentation)
April 16, 2021
N/A
US$ 45.00 million
Rwanda Biomedical Center
2021
US$ 45.00 million
N/A
December 22, 2021
June 30, 2025
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 30.00 |
| IBRD + IDA Commitment | 30.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | 15.00 |
| Total Project Cost** | 45.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
Detailed Financial Activity as of March 31, 2025
No data available.
Results Framework
No data available.